Literature DB >> 15983261

Nuclear magnetic resonance lipoprotein abnormalities in prediabetic subjects in the Insulin Resistance Atherosclerosis Study.

Andreas Festa1, Ken Williams, Anthony J G Hanley, James D Otvos, David C Goff, Lynne E Wagenknecht, Steven M Haffner.   

Abstract

BACKGROUND: Subjects with type 2 diabetes have smaller LDL and HDL particles in addition to higher levels of triglycerides and lower HDL cholesterol. Elevated insulin resistance, blood pressure, and dyslipidemia (including small dense LDL) predicted incident diabetes. In the Insulin Resistance Atherosclerosis Study (IRAS) we studied nuclear magnetic resonance (NMR) lipoprotein particle measures in prediabetic individuals, considering potentially modifying covariates, including insulin resistance, as directly measured using a frequently sampled intravenous glucose tolerance test. METHODS AND
RESULTS: Of 830 subjects who were nondiabetic at baseline, 130 (15.7%) developed diabetes after a mean follow-up of 5.2 years. Various lipoprotein abnormalities were found in prediabetic subjects compared with subjects who stayed nondiabetic at follow-up. In logistic regression analyses (demographically adjusted), VLDL particles, large VLDL, LDL particles, small LDL, large HDL, small HDL, VLDL size, LDL size, and HDL size were related to incident diabetes. The relation of VLDL size and small HDL to incident diabetes was independent of waist (odds ratio [OR] [95% CI], 1.43 [1.18 to 1.73] and 1.23 [1.01 to 1.51] for VLDL size and small HDL, respectively) and independent of conventionally (chemically) measured triglycerides and HDL cholesterol (OR [95% CI], 1.45 [1.18 to 1.78] and 1.30 [1.06 to 1.60], respectively). Insulin sensitivity attenuated the relation to incident diabetes of VLDL size (OR [95% CI], 1.25 [1.01 to 1.53]) but not of small HDL particles (OR [95% CI], 1.25 [1.02 to 1.54]).
CONCLUSIONS: We have shown a range of lipoprotein abnormalities in prediabetic individuals, including compositional changes in HDL and VLDL. These findings extend previous work indicating a proatherogenic state in healthy, nondiabetic subjects who subsequently develop diabetes.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15983261     DOI: 10.1161/CIRCULATIONAHA.104.512079

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  82 in total

1.  Clinical applications of advanced lipoprotein testing in diabetes mellitus.

Authors:  Danyaal S Moin; Anand Rohatgi
Journal:  Clin Lipidol       Date:  2011-08-01

2.  Opportunities for using lipoprotein subclass profile by nuclear magnetic resonance spectroscopy in assessing insulin resistance and diabetes prediction.

Authors:  Alexis C Frazier-Wood; W Timothy Garvey; Tara Dall; Robert Honigberg; Ray Pourfarzib
Journal:  Metab Syndr Relat Disord       Date:  2012-04-25       Impact factor: 1.894

Review 3.  Prediabetes and Cardiovascular Disease: Pathophysiology and Interventions for Prevention and Risk Reduction.

Authors:  Ben Brannick; Sam Dagogo-Jack
Journal:  Endocrinol Metab Clin North Am       Date:  2018-03       Impact factor: 4.741

4.  Reduced growth hormone secretion in obesity is associated with smaller LDL and HDL particle size.

Authors:  Hideo Makimura; Meghan N Feldpausch; Takara L Stanley; Noelle Sun; Steven K Grinspoon
Journal:  Clin Endocrinol (Oxf)       Date:  2012-02       Impact factor: 3.478

5.  APOL1 nephropathy risk variants are associated with altered high-density lipoprotein profiles in African Americans.

Authors:  Orlando M Gutiérrez; Suzanne E Judd; Marguerite R Irvin; Degui Zhi; Nita Limdi; Nicholette D Palmer; Stephen S Rich; Michèle M Sale; Barry I Freedman
Journal:  Nephrol Dial Transplant       Date:  2015-07-06       Impact factor: 5.992

6.  Lipoprotein insulin resistance index: a lipoprotein particle-derived measure of insulin resistance.

Authors:  Irina Shalaurova; Margery A Connelly; W Timothy Garvey; James D Otvos
Journal:  Metab Syndr Relat Disord       Date:  2014-06-24       Impact factor: 1.894

7.  Gene-Based Elevated Triglycerides and Type 2 Diabetes Mellitus Risk in the Women's Genome Health Study.

Authors:  Shafqat Ahmad; Samia Mora; Paul M Ridker; Frank B Hu; Daniel I Chasman
Journal:  Arterioscler Thromb Vasc Biol       Date:  2019-01       Impact factor: 8.311

8.  Lipoprotein insulin resistance score and risk of incident diabetes during extended follow-up of 20 years: The Women's Health Study.

Authors:  Paulo H N Harada; Olga V Demler; Sagar B Dugani; Akintunde O Akinkuolie; Manickavasagar V Moorthy; Paul M Ridker; Nancy R Cook; Aruna D Pradhan; Samia Mora
Journal:  J Clin Lipidol       Date:  2017-06-21       Impact factor: 4.766

9.  Polyunsaturated fatty acids modulate the effect of TCF7L2 gene variants on postprandial lipemia.

Authors:  Daruneewan Warodomwichit; Donna K Arnett; Edmond K Kabagambe; Michael Y Tsai; James E Hixson; Robert J Straka; Michael Province; Ping An; Chao-Qiang Lai; Ingrid Borecki; Jose M Ordovas
Journal:  J Nutr       Date:  2009-01-13       Impact factor: 4.798

10.  Impaired fasting glucose and impaired glucose tolerance have distinct lipoprotein and apolipoprotein changes: the insulin resistance atherosclerosis study.

Authors:  Carlos Lorenzo; Sara Hartnett; Anthony J Hanley; Marian J Rewers; Lynne E Wagenknecht; Andrew J Karter; Steven M Haffner
Journal:  J Clin Endocrinol Metab       Date:  2013-02-28       Impact factor: 5.958

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.